This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Acetyl-L-Carnitine

Well Researched

Amino Acid Derivative | Energy & Fat Metabolism

Aliases (6)

ALCAR · ALC · Acetylcarnitine · Acetyllevocarnitine · ALC-HCl · ACETYL-L-CARNITINE

TYPICAL DOSE

500-3000mg

Daily

ROUTE

Oral (capsule)

Oral

CYCLE

8-24 weeks

Continuous / daily

STORAGE

Room temp

Overview

What is Acetyl-L-Carnitine?

Acetyl-L-Carnitine (ALCAR) is the acetylated form of L-carnitine, a quaternary amine derived from lysine and methionine. It crosses the blood-brain barrier more readily than carnitine and is used as a nootropic, mitochondrial support agent, and adjunct in diabetic neuropathy and depression.

Key Benefits

Supports mitochondrial fatty-acid transport and ATP production, mild cognitive enhancement (especially in elderly and MCI), neuropathic pain reduction, and cholinergic support via acetyl-group donation.

Mechanism of Action

Donates the acetyl moiety to acetyl-CoA pools (fueling acetylcholine synthesis and Krebs cycle entry) and the carnitine moiety to facilitate long-chain fatty acid transport into mitochondria. Also exerts neuroprotective effects via NGF receptor sensitization.

▸Brand options6 known

ALCARALCAcetylcarnitineAcetyllevocarnitineALC-HClACETYL-L-CARNITINE

StatusOTC (US, EU); prescription Rx in some EU countries (e.g., Italy as Nicetile/Zibren for neuropathy)

Peptide Interactions

citicoline:

Synergistic

✅ Already in V4 (500 mg/day). ALCAR provides acetyl group, citicoline provides choline + cytidine → robust acetylcholine synthesis + phosphatidylcholine memb…

alpha-gpc:

Synergistic

✅ Same logic as citicoline; alpha-GPC is more bioavailable choline donor but less neuroprotective evidence than citicoline. Pick one, not both, with ALCAR.

taurine:

Synergistic

✅ Mitochondrial + osmotic + GABA-A-ergic complement. Both go AM. Stack-safe.

l-tyrosine:

Synergistic

✅ Catecholamine precursor; ALCAR's dopaminergic upregulation is downstream of tyrosine availability. Useful PRN under cognitive stress.

agmatine:

Synergistic

✅ NMDA modulation + neuroprotection on a different axis. Stack-safe.

PQQ:

Synergistic

✅ Mitochondrial biogenesis (PGC-1α) + ALCAR's mitochondrial fatty-acid transport — biogenesis + utilization combination. Common longevity stack.

R-ALA / ALA:

Synergistic

✅ Often co-formulated for neuropathy/diabetic stacks. Antioxidant + ALCAR mitochondrial support.

DHA/omega-3:

Synergistic

✅ Neuronal membrane substrate — already in V4 (2 g DHA). The "ACD" stack canonically pairs ALCAR + CDP-choline + DHA.

Caffeine + L-theanine:

Synergistic

✅ Stacks well; ALCAR smooths the caffeine curve and adds cognitive substrate. Useful AM combo for users in this archetype post-caffeine ramp.

Modafinil:

Synergistic

✅ Compatible; ALCAR provides metabolic substrate for the increased neural activity modafinil drives. Anecdotally improves the "tail" of modafinil sessions.

Bromantane:

Synergistic

✅ Listed as part of canonical "ACD stack" in encyclopedia; bromantane increases tyrosine-hydroxylase + dopamine synthesis, ALCAR upregulates D1.

Multiple high-dose AChE inhibitors

Avoid

(huperzine + galantamine + ALCAR + alpha-GPC + citicoline simultaneously) — risk of cholinergic excess (nausea, bradycardia, depression, "wet" feeling). ALCA…

NAD+

Synergistic

Both support mitochondrial function and energy metabolism through complementary pathways - L-Carnitine enhances fatty acid transport while NAD+ supports electron transport chain

Coenzyme Q10

Synergistic

CoQ10 and L-Carnitine work synergistically in mitochondrial energy production - combination shows enhanced benefits for heart health and exercise performance in studies

Quality Indicators

✓

Third-Party Tested

Quality products have third-party verification (NSF, USP, Informed Sport) for purity and potency.

✓

Correct Form Labeled

Product clearly specifies L-Carnitine form: base, L-Tartrate (LCLT), Acetyl (ALCAR), or Propionyl.

Slight Characteristic Odor

Some odor acceptable but strong or fishy smell may indicate degradation.

✗

Moisture Damage

Clumping, discoloration, or moisture indicates poor quality or storage degradation.

What to Expect

Onset
30-90 min (Tmax ~3.1 h after 500 mg oral; half-life ~4.2 h).
Peak
2-4 hours.

Side Effects & Safety 6

Side Effects

1GI upset (nausea, cramping, diarrhea) — primarily at >3 g/day; uncommon at 500 mg.
2Mild restlessness / overstimulation — dose-dependent; uncommon at 500 mg AM.
3Insomnia — especially with evening dosing.
4Headache.
5Vivid / unpleasant dreams.
6"Fishy" body odor — gut-microbiome-mediated TMA production exceeds FMO3 capacity to oxidize it. Worse in FMO3 hypomorphs (see Pharmacogenomics).

When to Stop

Mania / psychosis precipitation in bipolar disorder — multiple case reports document hypomanic/manic episodes triggered by ALCAR in BPI patients, including in remission. Contraindicated in bipolar disorder without psychiatric supervision.
Seizure exacerbation — case reports in epilepsy patients of increased seizure frequency on L-carnitine; ALCAR likely shares risk. Avoid if seizure history.
Hyperthyroid symptom modulation — L-carnitine antagonizes T3/T4 entry into cell nuclei; 2-4 g/day can attenuate hyperthyroid symptoms (this can be desirable in hyperthyroidism but problematic in hypothyroid patients on replacement).
A 2025 study (Krims-Davis et al, *Molecular Nutrition & Food Research*) directly compared L-carnitine vs acetylcarnitine: a single 1.5 g dose increased plasma TMAO >30-fold above baseline (from 2-3 µM to 40-50 µM). This applies to both forms — ALCAR is not a TMAO-safer alternative.
Acetylcarnitine has ~7.7× lower bioavailability than L-carnitine (much is hydrolyzed in gut to L-carnitine + acetate before absorption), which means gut bacteria see the L-carnitine and convert it to TMA, which the liver oxidizes to TMAO via FMO3.
TMAO is mechanistically linked to atherosclerosis (foam-cell formation, platelet hyperreactivity, endothelial dysfunction). The 2025 MESA study (>6,000 participants) found TMAO associated with incident cardiovascular events.
Mendelian randomization data on whether L-carnitine itself is causally cardioprotective vs harmful is mixed (2022 PMC study, "friend or foe?").
Acute TMAO elevation in a young, lean, fit person with no plaque is a much smaller absolute risk than chronic TMAO elevation in a 60-year-old with metabolic syndrome.
But the risk isn't zero and it's the type of slow, mechanism-driven process where 30+ years of daily 30× TMAO elevation is exactly the wrong intervention for someone whose explicit priority #3 is longevity.
Cycle: 8-12 weeks on, 4 weeks off. Allows TMAO to clear (TMAO half-life ~5-9 hours, but chronic baseline takes weeks to normalize).
Pre-load gut with TMAO-suppressing diet: high fiber (resistant starch, oats, legumes), polyphenols (berries, EVOO, dark chocolate), allicin/raw garlic (gut TMA-lyase inhibitor — acutely lowers TMAO), and a Mediterranean-pattern overall.
Probiotics: specific strains (Lactobacillus plantarum) modulate gut TMA production; evidence is preliminary but mechanistically clean.
Track TMAO directly: Cleveland HeartLab and others offer plasma TMAO assays. Strongly recommended if the user plans to use ALCAR daily for >6 months. Add to the June bloodwork panel.
Limit dose: 500 mg gives maybe half the TMAO bump of 1.5 g; the cognitive benefit at 500 mg is comparable for healthy users. Don't escalate without reason.
First 2 weeks: GI tolerance, sleep impact, mood changes.
3 months: confirm subjective benefit; if null, drop the supplement.
6 months: check TMAO, lipid panel, hs-CRP. Reassess.